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Hepatocellular cancer is the fifth most frequent cancer in
men and the eighth in women worldwide. Established
risk factors are chronic hepatitis B and C infection,
chronic heavy alcohol consumption, obesity and type 2
diabetes, tobacco use, use of oral contraceptives, and
aflatoxin-contaminated food. Almost 90% of all hepato-
cellular carcinomas develop in cirrhotic livers. In Western
countries, attributable risks are highest for cirrhosis due
to chronic alcohol abuse and viral hepatitis B and C
infection. Among those with alcoholic cirrhosis, the
annual incidence of hepatocellular cancer is 1–2%. An
important mechanism implicated in alcohol-related hepa-
tocarcinogenesis is oxidative stress from alcohol metab-
olism, inflammation, and increased iron storage. Ethanol-
induced cytochrome P-450 2E1 produces various reac-
tive oxygen species, leading to the formation of lipid per-
oxides such as 4-hydroxy-nonenal. Furthermore, alcohol
impairs the antioxidant defense system, resulting in mito-
chondrial damage and apoptosis. Chronic alcohol expo-
sure elicits hepatocyte hyperregeneration due to the
activation of survival factors and interference with reti-
noid metabolism. Direct DNA damage results from acet-
aldehyde, which can bind to DNA, inhibit DNA repair
systems, and lead to the formation of carcinogenic exo-
cyclic DNA etheno adducts. Finally, chronic alcohol
abuse interferes with methyl group transfer and may
thereby alter gene expression.
Keywords: acetaldehyde; cytochrome P4502E1;
hepatitis; methyl group transfer; reactive oxygen
species; retinoids.
Introduction
Recent epidemiological data (from the year 2000) indi-
cate that more than 560 000 new cases of hepatocellular
cancer (HCC) occurred worldwide, which accounted for
5.6% of all human cancers (Bosch et al., 2004). Thus,
HCC is the fifth most common malignancy in men and
the eighth in women. Age-adjusted incidence rates for
HCC were found to be extremely high in East and South-
east Asia, and in Africa (Ferlay et al., 2001). In Europe,
there is a gradually decreasing prevalence from South to
North. Overall, incidence rates for HCC were found to be
higher in males compared to females. The worldwide
HCC incidence rate doubled during the last two decades
and younger age groups are increasingly affected (El-
Serag and Mason, 2000; El-Serag, 2004). Risk factors for
HCC may explain the high prevalence in Asia and Africa
because of widespread infection with hepatitis B (HBV)
and hepatitis C virus (HCV). It is estimated that at least
75–80% of cases of primary HCC are attributable to
chronic viral hepatitis (Bosch et al., 1999). In addition,
other risk factors include chronic alcohol misuse, non-
alcoholic fatty liver disease (NAFLD), tobacco, oral con-
traceptives, and food contamination with aflatoxins. In
Europe and in the United States, estimates of attributable
risk are highest for chronic alcohol consumption, fol-
lowed by HCV and HBV infections (Donato et al., 2002;
Hassan et al., 2002). A major prerequisite for HCC is
established liver cirrhosis, as reflected by the observation
that 80–90% of all HCC develops in cirrhotic livers. Up
to 54–70% of patients with compensated cirrhosis due
to different etiologies and 50% of those with cirrhosis
due to chronic hepatitis C die from HCC (Fattovich et al.,
2004). The increase in HCC may also reflect better ther-
apeutic management of cirrhosis, resulting in longer sur-
vival and allowing the development of HCC. The 5-year
cumulative HCC incidence in cirrhosis is between 10%
and 30% in HBV and HCV infection, depending on the
geographic region, approximately 20% in hereditary
hemochromatosis and 8% in alcoholic cirrhosis (Fatto-
vich et al., 2004). Predictors of HCC in cirrhosis include
the severity of liver disease determined by the Child-
Pugh score (Bolondi et al., 2001), the disease activity,
reflected by serum transaminase activities (Benvegnu
et al., 1994; Tarao et al., 1999), and some histological
criteria, such as the presence of large cell changes (LCC)
(Borzio et al., 1995; Ganne-Carrie´ et al., 1996), macro-
nodules (Borzio et al., 2003) and markers for hyperre-
generation (Donato et al., 2001; Trere` et al., 2003).
However, some HCCs may occur in non-cirrhotic livers
of patients with HBV and HCV infection and chronic
inflammation of the liver associated with increased fibro-
genesis and hyperproliferation. However, chronic inflam-
mation is associated with oxidative stress, which plays a
major pathogenic role in most chronic liver diseases. As
for chronic hepatitis C, structural and non-structural viral
epitopes, such as the core protein or the NS5A protein,
were shown to elevate oxidative pressure (Liang and
Heller, 2004).
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In addition, patients with HBV infection show increased
excretion of etheno DNA adducts in their urine, which
results from the reaction of 4-hydroxynonenal (4-HNE)
with DNA bases (Bartsch and Nair, 2004). This increase
in etheno DNA adducts may arise from HBV-induced
chronic inflammation and overproduction of reactive
oxygen (ROS) and nitrogen species (RNS) and lipid per-
oxidation products. It is interesting that oxidative stress
leading to lipid peroxidation and end products such as
4-HNE results in mutation of the p53 gene at codon 249,
which is a hot spot in HCC (Hu et al., 2002). A strong
synergistic effect exists between HBV infection and afla-
toxin B1 exposure on incidence rates of HCC and on the
mutation of the p53 gene at codon 249 (Smela et al.,
2002). Although in cultured hepatocytes aflatoxin B1
binds at other codons than 249 of the p53 gene (Denis-
senko et al., 1998; Hu et al., 2002), it is possible that
HBV infection and aflatoxin B1 exposure could result in
enhanced lipid peroxidation, and lipid peroxidation prod-
ucts such as 4-HNE generated by HBV infection and afla-
toxin B1 exposure may damage codon 249 of the p53
gene, initiating carcinogenesis (Ross et al., 1992; Smela
et al., 2002). Thus, oxidative stress does occur in viral
hepatitis, but may be potentiated by concomitant afla-
toxin B1 exposure, which has been found in certain geo-
graphic areas of Africa and Asia.
It is beyond the scope of this review to discuss all risk
factors for HCC with respect to oxidative stress and
readers are referred to detailed reviews devoted to this
issue (Bre´chot, 2004; Fattovich et al., 2004; Kowdley,
2004; Liang and Heller, 2004; Yu and Yuan, 2004). The
present review focuses on alcohol-related HCC, with
special emphasis on oxidative stress. Other alcohol-relat-
ed mechanisms promoting the development of HCC are
outlined elsewhere (Stickel et al., 2002; Po¨schl and Seitz,
2004; Stickel and Seitz, 2004; McKillop and Schrum,
2005).
Epidemiology of alcohol and hepatocellular
cancer
Alcohol use is common in the U.S. and Western Europe
and is increasing in Asia. In the U.S., 7% of the adult
population meet the definition for alcohol misuse or
dependence, thereby exceeding the prevalence of hep-
atitis C by five-fold (Grant et al., 1994). Similar data exist
for some countries in Europe, including Germany, where
1.5 million individuals are alcohol-dependent and ap-
proximately 3 million people have alcohol-associated
organ damage (Deutsche Hauptstelle fu¨r Suchtfragen,
2003). Case-control studies in countries with a high prev-
alence of alcohol use and a moderate prevalence of viral
hepatitis, as well as studies from countries with a high
prevalence of chronic viral hepatitis and a lower preva-
lence of alcohol use, report that chronic ethanol con-
sumption is associated with an approximately two-fold
increased risk for HCC (Morgan et al., 2004). The odd
ratios increase further to five- to seven-fold when ethanol
use exceeds 80 g/day for more than 10 years (Tagger
et al., 1999; Hassan et al., 2002). In general, patients with
alcoholic liver cirrhosis show HCC incidence of 1–2%.
Although alcohol itself leads to liver cirrhosis and pro-
motes HCC, it is also a co-factor for the development of
HCC in other chronic liver diseases. Thus, chronic alco-
hol misuse may enhance and/or accelerate hepato-
carcinogenesis in patients with HBV and HCV infection,
with hereditary hemochromatosis, or with NAFLD. With
respect to viral hepatitis, alcohol may stimulate oxidative
stress and may, therefore, contribute to inflammation (see
below). It has been shown that chronic alcohol con-
sumption of more than 25 g/day leads to a 10-year earlier
occurrence of HCC in a Japanese population (Ohnishi,
1992) indicating an accelerating effect of alcohol in HBV-
driven hepatocarcinogenesis. Chronic alcohol misuse
also increases the risk of HCV infection (Inoue´ and Seitz,
2001). Whether this is due to impaired function of the
immune system following alcohol ingestion or relates
to the risky lifestyle of alcoholics is still unknown. In addi-
tion, alcohol may increase viral replication, possibly by
immunosuppression. Finally, alcohol may stimulate
inflammation and, thus, oxidative stress (Morgan et al.,
2004).
In hereditary hemochromatosis, hepatic iron overload
is a major factor in hepatocarcinogenesis (Kowdley,
2004) and alcohol enhances iron deposition in the liver,
resulting in increased oxidative stress (see below).
With respect to NAFLD, it has become clear that type
2 diabetics are at increased risk for HCC (El-Serag,
2004). The pathogenesis of NAFLD includes the accu-
mulation of fat in the liver, which may be predominantly
induced by hyperinsulinemia due to peripheral insulin
resistance. Free fatty acids induce cytochrome P4502E1
(CYP2E1) and lead to ROS (Neuschwander-Tetri and
Caldwell, 2003). Alcohol also increases CYP2E1 and
enhances this pathophysiological pathway. In addition,
tumor necrosis factor a (TNFa) is elevated in NAFLD and
alcoholic liver disease (ALD), resulting in further aggra-
vation of peripheral insulin resistance and in oxidative
stress. It has been shown that the relative risk for HCC
in type 2 diabetics is approximately 4, and it increases
to almost 10 for consumption of more than 80 g alcohol
per day (Hassan et al., 2002).
Mechanisms of alcohol-associated
carcinogenesis
Despite the substantial epidemiological data in humans
that chronic alcohol ingestion causes cirrhosis and HCC,
the mechanisms of the pathogenesis are still not com-
pletely understood. Alcohol by itself is not a carcinogen
when given to animals (Ketcham et al., 1963). However,
alcohol enhances chemically induced hepatocarcinoge-
nesis, especially when nitrosamines are used for tumor
induction (Po¨schl and Seitz, 2004). Thus, under certain
experimental conditions, alcohol may act as a tumor
promoter.
It should be pointed out that 30–50% of individuals
with HCC show a loss of heterozygosity of the long arm
of chromosome 4 (Laurent-Puig et al., 2001). In French
patients with HCC, a loss of 4Q34-3 in particular was
reported (Bluteau et al., 2002). However, a large propor-
tion of these patients were infected with HCV.
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Figure 1 Development of alcoholic liver disease following
chronic heavy alcohol abuse.
p.a., per annum.
Various mechanisms may contribute to alcohol-asso-
ciated carcinogenesis, including: (1) chronic inflammation
resulting in increased oxidative stress, such as in alco-
holic steatohepatitis (ASH); (2) acetaldehyde and its det-
rimental effect on proteins and DNA; (3) induction of
CYP2E1 leading to increased ROS production, lipid
peroxidation and DNA damage; (4) a decrease in anti-
oxidant defense and DNA repair; (5) disturbed methyl
transfer associated with DNA hypomethylation; (6)
decreased hepatic retinoic acid (RA); (7) iron overload;
and (8) profound impairment of the immune system.
Alcohol and inflammation
When alcohol consumption is regularly above a certain
threshold, fatty liver develops in almost 100% of cases.
However, only 30% of these patients develop alcoholic
fibrosis either with or without inflammation, and only
10–20% progress to liver cirrhosis (Becker et al., 1996)
(Figure 1). It has been speculated that genetic aspects
may play a predominant role, explaining why not every
alcoholic develops advanced liver disease. Although
polymorphisms of genes involved in ALD have been
intensively studied, the results so far are disappointing
(Stickel and O¨sterreicher, 2006). HCC almost always
occurs in alcoholic cirrhosis. Recently it has been shown
that some histological phenotypes of hepatocytes,
observed in experimental alcoholic hepatitis long before
cancer develops, may act as an early predictive marker
for HCC development. Thus, in a mouse model the Mal-
lory body-forming cell phenotype induced by diethyldi-
thiocarbamate seemed to be preneoplastic in nature
(French et al., 2005).
The mechanism in the pathogenesis of ASH includes
the uptake of intestinal endotoxins from the gut to the
liver via the portal vein. These endotoxins (lipopolysac-
charides) bind to the CD14/toll 4 receptor complex of
Kupffer cells in the liver, leading to intracellular signal
transduction, with the release of proinflammatory cyto-
kines, particularly TNF-a, eicosanoids, ROS and nitric
oxide (NO) (Jarvelainen et al., 1999; Hines and Wheeler,
2004). It has been shown in animal experiments that both
the administration of antibiotics to reduce endotoxemia
and the inactivation of Kupffer cells with gadolinium chlo-
ride prevent liver injury (Thurman, 1998). CD 14 or CD
14-coupled toll like receptor 4 knockout mice with less
TNF-a production are also resistant to alcohol toxicity
(Uesugi et al., 2001; Yin et al., 2001). Furthermore, inhi-
bition of TNF-a by TNF-a antibodies or by the use of a
TNF-a receptor knockout mouse model also protects
against alcohol-induced liver injury (Hines and Wheeler,
2004). TNF-a results – after binding to its receptor
(TNFa-R1) – in cell apoptosis. However, hepatocytes are
resistant to the proapoptotic effects of binding to its
receptor in cell proliferation, necrosis, or apoptosis,
depending on the TNF-a, owing to the concomitant
induction of antiapoptotic signals such as NF-kB (Wajant
et al., 2003). TNF-a also induces OS, which in turn
enhances TNF-a toxicity. The mechanism is not yet fully
understood.
Figure 2 shows a simplified scheme of the pathogen-
esis of ASH. Besides other factors, interleukin 6 (IL-6) is
significantly elevated in alcoholic patients with advanced
liver disease (Urbaschek et al., 2001). It has to be pointed
out that IL-6 inhibits hOGG1, an important repair enzyme
for 8-oxo-guanosine adducts (Bartsch and Nair, 2004).
IL-6 is also antiapoptotic through upregulation of the
antiapoptotic gene mcl-1 (Lin et al., 2001). Both factors
favor carcinogenesis (Figure 3).
Liver cirrhosis may develop from ASH. However, it is
not clear whether ASH with its enormous inflammation-
driven oxidative stress and hyperproliferation is an impor-
tant prerequisite for cancer development some decades
later in the state of cirrhosis. Therefore, it would be
important to know whether cirrhotic patients who went
through ASH have an increased risk for HCC compared
to those without ASH.
Ethanol metabolism and hepatocarcinogenesis
Figure 4 illustrates ethanol metabolism and its interfer-
ence with metabolic pathways important in hepato-
carcinogenesis.
Acetaldehyde The first and major metabolite of eth-
anol oxidation is acetaldehyde. There is increasing evi-
dence that acetaldehyde rather than alcohol itself is
responsible for the cocarcinogenic effect of alcohol
(Po¨schl and Seitz, 2004). Acetaldehyde is highly toxic,
mutagenic and carcinogenic. It interferes at many sites
with DNA synthesis and repair, and may, consequently,
result in tumor development (IARC, 1999). Numerous in
vitro and in vivo experiments in prokaryotic and eukaryo-
tic cell cultures, as well as in animal models, have shown
that acetaldehyde has direct mutagenic and carcinogenic
effects. It causes point mutations in the hypoxanthine-
guanine-phosphorybosyl transferase locus in human
lymphocytes, and induces sister chromatide exchanges
and gross chromosomal aberration (Obe et al., 1986;
Dellarco, 1988; Helander and Lindahl-Kiessling, 1991). It
induces inflammation and metaplasia of tracheal epithe-
lium, delays cell cycle progression and enhances cell
injury associated with hyperregeneration (Simanowski
et al., 1994; Seitz et al., 2001). Acetaldehyde binds to
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Figure 2 Simplified pathogenesis of alcoholic hepatitis.
Bacterial endotoxins are translocated from the leaky gut to the
portal vein and are delivered to the liver, where they bind to toll-
like receptors (TLR) and CD14 receptors of Kupffer cells (KC).
As a result, chemokines and cytokines (interleukins 1, 4, 6, 8,
10) are released, including TGF-b and TGF-a. TGF-a binds to
its receptor, leading to necrosis, apoptosis and activation of NF-
kB, among other effects.
Figure 3 Effect of ethanol and acetaldehyde on DNA damage
and repair.
Alcohol and free fatty acids induce cytochrome P-4502E1 and
lead to the generation of reactive oxygen species (ROS) and
reactive nitrogen species (RNS), which can be neutralized by the
antioxidative defense system. Since this system is overloaded
by an increased burden of ROS/RNS and due to inhibition by
acetaldehyde, DNA damage may occur. Adequate DNA repair
does not take place, since acetaldehyde, as well as nitric oxide
(NO) produced by inducible nitric-oxide synthase (iNOS), inhibits
the DNA repair systems. In addition, interleukin 6 (IL-6) released
in alcoholic hepatitis and induced by NF-kB also inhibit DNA
repair and apoptosis.
O6-GMT, O6 guanine-methyltransferase; 8-oxo-G-DNA-G, 8-
oxo-guanine-DNA glycosylase; 3M-A-DNA-G, 3-methyladenine-
DNA-glycosylase; MMS-T-DNA-G, mismatch-specific thym-
idine-DNA glycosylase.
proteins, resulting in structural and functional alterations,
and decreases antioxidative defense systems by binding
to glutathione, thus increasing oxidative stress indirectly.
Acetaldehyde also injures microtubules and mitochon-
dria. Decreased microtubular function leads to inhibition
of the secretion of macromolecules such as very-low-
density lipoproteins from the liver. Decreased mitochon-
drial function results in inhibition of fatty acid oxidation
and ATP formation. Both factors favor the occurrence of
fatty liver (Lieber, 1994). In addition, mitochondrial dam-
age induces apoptosis, but also survival factors such as
NF-kB.
It has also been shown that acetaldehyde interferes
with the DNA repair machinery. Acetaldehyde directly
inhibits O6-methylguanosyl transferase, an enzyme
important for the repair of DNA adducts (Espina et al.,
1988). In the liver, acetaldehyde forms adducts with intra-
cellular proteins and DNA, resulting in morphological and
functional impairment of the cell, and a humoral immune
reaction towards de novo generated antigens. Binding
to DNA and the formation of stable adducts represents
one mechanism by which acetaldehyde could trigger the
occurrence of replication errors and/or mutations in
oncogenes or tumor suppressor genes. The occurrence
of stable DNA adducts has been shown in different
organs of alcohol-fed rodents and in leukocytes of alco-
holics (Fang and Vaca, 1997). It has been shown that the
major stable DNA adduct N2-ethyl desoxyguanosine (N2-
Et-dG) indeed serves as a substrate of eukaryotic DNA
polymerase (Matsuda et al., 1999). More recently, another
DNA adduct of acetaldehyde namely 1,N2-propano-des-
oxyguanosine (PdG) has been identified (Brooks and
Theruvathu, 2005). Its generation occurs in the presence
of basic amino acids, histones and polyamines. While
N2-Et-dG is non-mutagenic and may be used as a mark-
er for chronic alcohol ingestion, PdG has mutagenic
properties. The action of acetaldehyde on DNA meta-
bolism is summarized in Figure 3. According to the Agen-
cy for Research on Cancer, there is sufficient evidence
to classify acetaldehyde as a carcinogen in experimental
animals (IARC, 1999).
Recent and striking evidence of the causal role of acet-
aldehyde in ethanol-associated carcinogenesis was iden-
tified in genetic linkage studies in alcoholics. Individuals
who accumulate acetaldehyde due to polymorphism
and/or mutations in the gene coding for enzymes respon-
sible for acetaldehyde generation and detoxification have
been shown to have an increased cancer risk (Yokoyama
et al., 1998). In this context it is interesting that in Cau-
casians polymorphism of alcohol dehydrogenase 1C
(ADH1C) exists and that the allele ADH1C*1 encodes for
an enzyme with a high capacity to generate acetalde-
hyde. We recently identified the genotype ADH1C*1/1 as
an independent risk factor for the development of alco-
hol-associated HCC among heavy drinkers, indicating a
genetic predisposition of individuals carrying this geno-
type (Homann et al., 2006).
Cytochrome P-4502E1 and ROS generation Several
enzymatic systems, including the CYP2E1-dependent
microsomal mono-oxygenase system, the mitochondrial
respiratory chain and the cytosolic enzymes xanthine
oxidase and aldehyde oxidase, have been implicated as
sources of O2- and H2O2 in hepatocytes during ethanol
oxidation (Albano, 2002). Alcohol-mediated free radical
formation may be due to enhanced electron leakage from
the mitochondrial respiratory chain, along with stimula-
tion of NADH shuttling into mitochondria (Bailey and
Cunningham, 2002), to an interaction between N-ace-
tylsphingosine (from TNF-a) and mitochondria (Garcia-
Ruiz et al., 2000), to activated phagocytes in the liver
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Figure 4 Ethanol metabolism and its role in alcoholic liver disease and carcinogenesis.
Ethanol is metabolized by alcohol dehydrogenases (ADHs), which reveal polymorphisms, and by cytochrome P-4502E1, which is
inducible by chronic alcohol ingestion. The product acetaldehyde can be further metabolized by acetaldehyde dehydrogenase (ALDH).
Acetaldehyde binds to proteins, forming neoantigens, and to DNA, forming DNA adducts. It damages mitochondria, with loss of
function. As a result, fatty liver develops. Mitochondrial damage also initiates apoptosis and activation of the nuclear survival factor
NF-kB. Alcohol-induced alterations in methyl-group transfer lead to DNA hypomethylation and membrane alterations. CYP2E1 also
produces reactive oxygen species (ROS), which lead to lipid peroxidation, protein oxidation and DNA adducts. It also metabolizes
drugs, activates various procarcinogens, and decreases retinol and retinoic acid.
COX2, cyclo-oxygenase 2; MnSOD, Mn-superoxide dismutase; NAD, nicotine adenine dinucleotide.
(Bautista, 2002), to hepatic iron overload (see below), and
to nitric oxide (NO) (Chamulitrat and Spitzer, 1996). The
reaction of NO with O2- results in the formation of peroxy-
nitrite (ONOO-), which is highly reactive and impairs cell
function (Beckman and Koppenol, 1996). Inducible nitric
oxide synthase (iNOS) is stimulated by ethanol and iNOS
knockout mice are protected against alcohol-induced
liver injury (Arteel, 2003). Although all these factors may
contribute to the generation of ROS following alcohol
ingestion, animal experiments have convincingly dem-
onstrated the important role of CYP2E1 in the production
of ROS and ALD.
Chronic alcohol consumption leads to a 10–20-fold
induction of CYP2E1, which metabolizes ethanol to acet-
aldehyde. This cytochrome is also involved in the acti-
vation of various cocarcinogens to their ultimate car-
cinogens, including nitrosamines, aflatoxins, and poly-
cyclic hydrocarbons. The interaction between ethanol
and procarcinogen metabolism is complex and may
depend on, among other factors, the degree of CYP2E1
induction, the chemical structure of the procarcinogen,
and the presence or absence of ethanol in the body dur-
ing procarcinogen metabolism. The events in this setting
are reviewed elsewhere (Seitz and Osswald, 1992).
It has been shown that the concentration of CYP2E1
in the liver is correlated with the generation of hydroxy-
ethyl radicals (HERs) and thus with lipid peroxidation
(Dupont et al., 1998). HERs bind to proteins and form
neoantigens (Albano et al., 1993). Antibodies against
HER-derived epitopes are detectable in the sera of
patients with ALD (Clot et al., 1995, 1996). Induction of
CYP2E1 resulted in ALD in animals, and inhibition of
CYP2E1 was associated with an improvement in the
damage (Gouillon et al., 2000). It has been concluded
that this is mainly due to the stimulation and inhibition,
respectively, of free radical formation. The role of
CYP2E1 induction and cell injury has been studied in
detail in the liver. For example, oxidized DNA products
have been found to be lower in CYP2E1 knockout mice
compared to wild-type mice (Bardag-Gorce et al., 2000;
Bradford et al., 2005), whereas more pronounced hepatic
damage was observed in transgenic mice overexpressing
CYP2E1 (Morgan et al., 2002).
Although NADPH oxidase knockout mice do not pro-
duce a radical detectable by spin trapping, oxidative
DNA damage does occur in these animals. Moreover,
since CYP2E1 knockout mice reveal less DNA damage,
at least two sources of oxidants may have additive
effects on each other.
In humans, the extent of CYP2E1 induction is individ-
ually determined, but may be significant following the
ingestion of 40 g alcohol per day, corresponding to
400 ml of 12.5 vol.% wine, for 1 week (Oneta et al.,
2002). ROS produced by CYP2E1 lead to lipid peroxi-
dation, with the generation of malondialdehyde (MDA)
and 4-HNE (Aleynik et al., 1998). 4-HNE not only leads
to a mutation at codon 249, which makes cells more
resistant to apoptosis and shows some growth advan-
tages (Hu et al., 2002), but also causes the production
of exocyclic DNA etheno adducts (´dA), which can be
measured in urine and determined immunohistologically
in the liver (Frank et al., 2004). It has been shown that
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these adducts are present in alcoholic fatty, liver but are
more pronounced in advanced ALDs such as cirrhosis.
Adduct formation is somewhat comparable with those
found in iron storage disorders such as hemochromato-
sis and Wilson’s disease. Some evidence suggests that
the degree of CYP2E1 induction in cell cultures can be
correlated with the extent of ´dA.
With respect to the effect of ethanol on the generation
of mitochondrial ROS, readers are referred to recent
review articles (Hoek et al., 2002; Albano, 2005).
The steady-state level of DNA adducts is influenced by
various factors and is elevated under the following con-
ditions: (1) reduction of the antioxidative defense system;
(2) diminished glutathione S-transferase due to genetic
polymorphism; (3) an impaired DNA repair system; and
(4) reduced apoptosis. Chronic ethanol ingestion may
favor factors 1, 2, and 4 either directly or via chronic
inflammation.
Alteration of the antioxidative defense system and
inhibition of DNA repair The increased oxidative
stress observed during ethanol metabolism leads to an
increase in the requirement for glutathione and a-tocoph-
erol. Chronic alcoholism also increases the requirement
for methyl groups, and dietary methyl deficiency may
enhance hepatic carcinogenesis (Stickel and Seitz,
2004). In ALD, the hepatic glutathione content is signifi-
cantly reduced. It has been shown that supplementation
with N-acetylcysteine prevents liver injury in experimental
alcohol-induced hepatic injury (Limuro et al., 2000; Ronis
et al., 2005). Since mitochondrial glutathione content is
reduced by 50–85% (Fernandez-Checa et al., 1991), it is
not surprising that this favors mitochondrial dysfunction
and lipid peroxidation, and impairs hepatocyte tolerance
to TNF-a (Fernandez-Checa and Kaplowitz, 2005). In
addition, a-tocopherol is also reduced due to enhanced
oxidation (Kawase et al., 1989). More recently, a de-
crease in enzyme activity and the immunoreactive protein
concentration of hepatic (Cu-Zn)-superoxide dismutase,
catalase and glutathione peroxidase in experi-
mental ALD has been reported (Rouacht et al., 1997),
which inversely correlated with the extent of lipid peroxi-
dation and hepatic injury (Polavarapu et al., 1998). Sub-
sequently, selenium deficiency has been reported in
alcoholics (Seitz and Suter, 2002).
Chronic alcohol consumption also inhibits hepatic DNA
repair induced by nitrosamines. This is due to acetalde-
hyde-related inhibition of O6-guanine-methyl transferase
(Espina et al., 1988) (Figure 3).
Disturbed methyl group transfer
Changes in the degree of methylation of cytosine are fre-
quently encountered in human cancers, but their rele-
vance as an epigenetic factor in carcinogenesis is only
partially understood (Counts and Goodman, 1995). How-
ever, DNA methylation is an important determinant in
controlling gene expression, whereby hypermethylation
has a silencing effect on genes and hypomethylationmay
lead to increased gene expression. In hepatocarcinoge-
nesis, general hypomethylation may be coupled with are-
as of regional hypermethylation. Thus, hypermethylation
of tumor suppressor genes can result in decreased gene
transcription of p53 and HIC-1 (Kanai et al., 1999), and
hypomethylation of certain oncogenes such as c-myc
and c-N-ras may lead to dedifferentiation and prolifera-
tion (Wainfan et al., 1989; Wainfan and Poirier, 1992;
Shen et al., 1998).
Recently, it has been suggested that aberrant DNA
hypermethylation may be associated with genetic insta-
bility, as determined by the loss of heterozygosity and
microsatellite instability in human HCC due to chronic
viral hepatitis (Kanai et al., 2000; Kondo et al., 2000).
Iwata et al. (2000) detected hypermethylation of the 14-
3-3 s gene, which has been implicated as a key inducer
of cell cycle arrest associated with p53 in 89% of human
HCC investigated. However, genetic alterations in animal
models and human hepatocarcinogenesis differ sub-
stantially. Thus, it was shown that activation of N-myc
and c-myc oncogenes is frequent in woodchuck hepatitis
virus-associated HCC, while no p53 mutations were
found. This mutational pattern is reversed in humans,
where p53 are frequent and oncogene activation seems
to play only a minor role (Hui and Makuuchi, 1999).
Importantly, modifications of the degree of hepatic
DNA methylation have also been observed in experi-
mental models of chronic alcoholism (Garro et al., 1991;
Choi et al., 1999). Hypomethylation is a plausible con-
sequence of metabolic alterations in the setting of etha-
nol consumption. In fact, alcohol has a marked im-
pact on hepatic methylation capacity, as reflected by
decreased levels of S-adenosylmethionine (SAM), an
important methyl group donor, and increased levels of S-
adenosylhomocysteine (SAH), resulting in an up to 2.5-
fold decrease in the SAM/SAH ratio (Lieber et al., 1990;
Trimble et al., 1993; Stickel et al., 2000). Several mech-
anisms have been suggested by which ethanol could
interact with one-carbon metabolism and DNA methyla-
tion and thereby enhance carcinogenesis (Lu and Mato,
2005). (1) Chronic alcohol interacts with intake, absorp-
tion and subsequent metabolism of B vitamins involved
in hepatic transmethylation reactions, namely folate and
pyridoxal-59-phosphate (vitamin B6), resulting in impaired
methyl group synthesis and transfer (Lumeng and Li,
1974; Labadarios et al., 1977; Savage and Lindenbaum,
1986; Gloria et al., 1997; Stickel et al., 2000). (2) Ethanol
reduces the activity of methionine synthetase, which
remethylates homocysteine to methionine with methyl-
tetrahydrofolate as the methyl donor (Barak et al., 1993;
Lieber, 1994). (3) Chronic alcohol consumption decreases
glutathione levels, a reductive tripeptide that is synthe-
sized from homocysteine via trans-sulfuration in the liver,
and thereby enhances the susceptibility of the liver to
alcohol-related peroxidative damage (Speisky et al.,
1985; Lieber, 1994). (4) Alcohol can inhibit the activity of
DNA methyltransferase, which transfers methyl groups
to DNA in rats (Lieber et al., 1990), a finding that could
not, however, be confirmed in humans (Miyakawa et al.,
1996).
To date, it is well established that dietary depletion of
lipotropes, including methionine, choline, betaine, SAM
and folate, leads to DNA hypomethylation, particularly
hypomethylation of oncogenes (that is c-Ha-ras, c-Ki-ras
and c-fos) and to DNA strand breaks, all of which are
associated with an increased incidence of HCC in rats
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Figure 5 Production of etheno-DNA adducts via induction of
cytochrome P-4502E1 and lipid peroxidation.
FFA: free fatty acids.
Figure 6 Progression of alcoholic and non-alcoholic fatty liver
to advanced liver disease in fatty liver.
Cytochrome P-4502E1 (CYP2E1) is induced by ethanol and/or
free fatty acids, which results in the generation of reactive oxy-
gen species (ROS). In addition, tumor necrosis factor a (TNF-a)
is generated from fatty tissue or released from Kupffer cells (KC)
via gut-derived endotoxins. TNF-a leads to insulin resistance
and to the production of ROS. Both TNF-a and ROS result in
alteration of cell biology favoring the progression of liver disease
and carcinogenesis.
(Zapisek et al., 1992; Pogribny et al., 1995). Figure 5 illus-
trates methyl transfer and alcohol interactions.
Interaction with retinoids
Another important issue in hepatocarcinogenesis relates
to the metabolism and functions of retinoids (Seitz, 2000;
Wang, 2005). Chronic alcohol consumption interferes
strikingly with the metabolism of retinol and retinoic acid
(RA) factor (see below). Reduced serum and hepatic vita-
min A concentrations have been shown in chronic alco-
holics (Leo and Lieber, 1982). This is of particular
importance, as RA is synthesized from retinol via various
enzymatic steps involving microsomal and cytosolic ADH
and ALDH. RA has profound effects on cellular growth
and differentiation via two families of RA nuclear recep-
tors (RAR-a, -b and -x, and RXR-a, -b and -x), which
mediate RA-induced gene transcription (Chambon,
1996). In a series of experiments, the effects of alcohol
on retinol and RA metabolism, on transcellular RA sig-
naling, and on early events of carcinogenesis have been
investigated. Chronic alcohol consumption affects sev-
eral aspects of degradation in the liver and increased
mobilization of retinol from the liver to other organs (Leo
and Lieber, 1999; Seitz, 2000). These ethanol-induced
changes may result in decreased hepatic concentrations
of both retinol and retinyl esters, which are the metabol-
ically active precursors of RA. Furthermore, it has been
demonstrated that ethanol acts as a competitive inhibitor
of retinol oxidation in the liver, thereby counteracting the
biosynthesis of RA (Wang et al., 1998). Accordingly, RA
levels in the liver of ethanol-fed rats were significantly
decreased compared with control pairs fed an isocaloric
control diet containing equal amounts of vitamin A (Liu
et al., 2001). It has recently been shown that ethanol
causes an additional local deficiency of RA in the liver,
resulting from enhanced RA catabolism due to induction
of CYP2E1 (Chung et al., 2001). In the same study, treat-
ment of ethanol-fed rats with chlormethiazole, a specific
CYP2E1 inhibitor, restored both hepatic and plasma RA
concentrations to normal levels. Enhancement of RA
catabolism by ethanol in vitro was inhibited by CYP2E1
antibodies and chlormethiazole, while catabolism of RA
into polar metabolites was abolished completely by non-
specific cytochrome P450 inhibitors. Lastly, chronic alco-
hol consumption resulted in a functional downregulation
of RA receptors and up to eight-fold higher expression
of the AP-1 (c-jun and c-fos) transcriptional complex
(Wang et al., 1998). This explains parenchymal hyperpro-
liferation, as AP-1 is a central complex downstream of
various growth factors, oncogenes and tumor promoters
(Chiu et al., 1988). Most interestingly, supplementation of
animals with all-trans-RA to normal RA levels not only led
to a decrease in AP-1 (c-jun and c-fos) gene expression,
but also to normalization of hepatic proliferation, as
expressed by proliferating cell nuclear antigen expression
(Chung et al., 2001). In summary, these data suggest that
low hepatic RA levels due to chronic alcohol misuse may
favor proliferation and malignant transformation of hepa-
tocytes via upregulation of AP-1 (c-jun and c-fos) gene
expression. (Figures 6 and 7).
Accordingly, retinoids inhibit chemically induced liver
cancer in animals (Moreno et al., 2002). In addition, an
inverse relationship between the risk of HHC and RA
levels has been observed (Yu et al., 1995, 1999) and the
administration of a synthetic retinoid prevented the
occurrence of a secondary cancer in patients with HCC
(Muto et al., 1999).
Iron and oxidative stress
As pointed out above, the risk for HCC in hereditary
hemochromatosis is approximately 200-fold higher than
in the general population. The increased risk of HCC may
be the result of generation of ROS from free iron, directly
through the Fenton reaction or indirectly through accel-
eration of lipid peroxidation (Petersen, 2005). Iron leads
to DNA strand breaks and to p53 mutation via 4-HNE, a
major lipid peroxidation product (Marrogi et al., 2001;
Bartsch and Nair, 2004). In addition, these products also
result in DNA adducts, as well as in an activation of stel-
late cells, followed by enhanced fibrogenesis. Chronic
alcohol ingestion increases the intestinal uptake and
hepatic deposition of iron. It has been shown that the
presence of iron, particularly low-molecular-weight non-
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Figure 7 Effect of ethanol on methyl group transfer.
Chronic ethanol consumption (A) results in a decrease in folic acid, and inhibition of methionine synthase (MS), methionine adeno-
sinetransferase (MAT) and phosphoethanolamine methyltransferase (PEMT). As a result, hepatic levels of S-adenosylmethionine
(SAME) are decreased and homocysteine concentrations are increased, leading to endoplasmic reticulum (ER) stress.
THF, tetrahydrofolate; NADPq, nicotine adenine dinucleotide phosphate; NADPH, nicotine adenine dinucleotide phosphate (reduced);
PPE, polyenylphosphoethanolamine; PPC, polyenylphosphocholine.
protein iron complexes, exacerbates oxidative damage
by alcohol and that it stimulates hepatic macrophages to
produce ROS and pro-inflammatory cytokines (Tsuka-
moto et al., 1999; Caro and Cederbaum, 2004). Although
the mechanism of ethanol-associated hepatic iron dep-
osition is still unclear, it has been speculated that oxi-
dative modification of cytosolic iron regulatory protein 1
(IRP1) causes repression of ferritin synthesis and stimu-
lation of transferring receptor synthesis, with increased
iron uptake (Rouault, 2003).
Summary and conclusions
HCC is a frequently occurring cancer worldwide. A vari-
ety of risk factors exist, including HBV and HCV infection,
NAFLD, heavy alcohol consumption and aflatoxin expo-
sure. Most HCCs occur in cirrhotic livers and the com-
mon mechanism for hepatocarcinogenesis is chronic
inflammation associated with severe oxidative stress.
Oxidative stress in ALD is due to a variety of factors,
such as the production of acetaldehyde from ethanol, the
induction of CYP2E1, a decrease in the antioxidative
defense system, disturbed metabolism of retinoids and
methyl groups, and iron overload. Conclusions drawn
from the fact that oxidative stress is a major pathophy-
siological factor in the development of HCC may include
preventive and interventional therapeutic approaches
with antioxidants. Such approaches have been initiated
with retinoids, but clinical data are still inconclusive and
further clinical studies are urgently needed. However, the
best method for prevention of HCC is vaccination against
hepatitis B, avoidance of infection with hepatitis C by
optimal hygienic measures, avoidance of food contami-
nated with aflatoxins, reduction of alcohol intake to safe
limits (20–30 g for men, 10–20 g for women) and main-
tenance of a normal body weight to avoid diabetes and
metabolic syndrome. Finally, early diagnosis of hereditary
hemochromatosis with consequent treatment by phle-
botomy will prevent the occurrence of HCC.
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